Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001628280-23-041960

Director acquired 14,987 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Waddill William D. Director 2023-12-15 Grant or award +14,987 $25.41 $380,820 51,804 D
Loading xslF345X05/wk-form4_1703018485.xml…